Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB-002 in Distal Subungual Onychomycosis
NCT00453271Phase 2Completed
- Sponsor
- BlueWillow Biologics
- Start
- Jan 2007
- Primary completion
- Oct 2008
- Modality
- Lipid-based Nanoparticles
- Countries
- 2
01
Overview
A Phase 2 trial of NB-002 in distal subungual onychomycosis (DSO), sponsored by BlueWillow Biologics. Started Jan 2007; status: completed.
02
Drugs
NB-002
03
Conditions
distal subungual onychomycosis (DSO)
Beyond the preview
Go deeper on NCT00453271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453271.